ClinicalTrials.Veeva

Find clinical trials for Non-Hodgkin Lymphoma in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Mantle-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Pittsburgh, PA, USA:

Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)

017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....

Active, not recruiting
Follicular Lymphoma
Mantle-cell Lymphoma
Biological: JCAR017 (lisocabtagene maraleucel) single-dose schedule
Biological: JCAR017 (lisocabtagene maraleucel) 2-dose schedule

Phase 1

Juno Therapeutics

Pittsburgh, Pennsylvania, United States and 13 other locations

This study will enroll approximately 160 adult participants who have relapsed or refractory (r/r) iNHL to be infused with the study treatment, axicab...

Active, not recruiting
Marginal Zone Lymphoma
Indolent Non-Hodgkin Lymphoma
Biological: axicabtagene ciloleucel
Drug: Fludarabine

Phase 2

Gilead Sciences
Gilead Sciences

Pittsburgh, Pennsylvania, United States and 18 other locations

bispecific antibody, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) who have received 2 or mo...

Enrolling
B-cell Non Hodgkin Lymphoma
Follicular Lymphoma
Drug: AZD0486 IV

Phase 1

AstraZeneca
AstraZeneca

Pittsburgh, Pennsylvania, United States and 27 other locations

This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....

Enrolling
T-cell Lymphoma
Cutaneous T-cell Lymphoma
Drug: Fenretinide

Phase 1

SciTech Development

Pittsburgh, Pennsylvania, United States and 4 other locations

with polatuzumab vedotin in participants with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma...

Active, not recruiting
B-cell Non-Hodgkin Lymphoma
Drug: Polatuzumab vedotin
Drug: Mosunetuzumab (SC)

Phase 1, Phase 2

Roche
Roche

Pittsburgh, Pennsylvania, United States and 28 other locations

Phase 1, open-label, multicenter study of WTX-330 administered as a monotherapy to patients with advanced or metastatic solid tumors or non- ...

Enrolling
Non-Hodgkin Lymphoma
Advanced or Metastatic Solid Tumors
Drug: WTX-330

Phase 1

Werewolf Therapeutics

Pittsburgh, Pennsylvania, United States and 8 other locations

This is a Phase I/II, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK...

Enrolling
Non-Hodgkin's Lymphoma
Drug: Glofitamab
Drug: Obinutuzumab

Phase 1, Phase 2

Roche
Roche

Pittsburgh, Pennsylvania, United States and 40 other locations

with other standard of care (SOC) agents in participants with B-cell Non-Hodgkin Lymphoma (B-NHL).The trial consists of 10...

Enrolling
Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: rituximab and lenalidomide
Drug: gemcitabine and oxaliplatin

Phase 1, Phase 2

Genmab
Genmab

Pittsburgh, Pennsylvania, United States and 63 other locations

This study will evaluate the safety and efficacy of 1A46 in adult patients with advanced CD20 and/or CD19 positive B-cell non-Hodgkin...

Enrolling
Non-Hodgkin's Lymphoma (Disorder)
Acute Lymphoid Leukemia, Disease (Disorder)
Drug: 1A46 Injection

Phase 1, Phase 2

Chimagen Biosciences

Pittsburgh, Pennsylvania, United States and 4 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...

Enrolling
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

AbbVie
AbbVie

Pittsburgh, Pennsylvania, United States and 49 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems